Sep 1, 2007 Merck's arthritis drug Vioxx is back in court today as an 11th case goes to trial, but the legal landscape of the ongoing litigation has changed considerably. Helen Palmer reports.
Sep 1, 2007 Federal investigators got their first guilty plea in the stock options backdating scandal. The outcome could give executives at the other 140 companies involved even more to worry about. Bob Moon reports.